Multinational clinical studies are increasing, KFDA says

The number of multinational clinical trials conducted by multinational pharmaceutical companies in Korea reached 303 last year, showing a 56-percent increase from a year earlier, according to the Korea Food and Drug Administration.

“The increase in multinational clinical tests is a sign that Korea's clinical infrastructure and technology have nearly reached the same level as those of advanc...